Eisenmenger Syndrome Treatment Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Eisenmenger Syndrome Treatment Market : Overview Eisenmenger Syndrome develops due to high blood pressure in the lungs, which is known as pulmonary hypertension. Pulmonary hypertension occurs due to certain congenital heart defects that cause the blood to flow from left side of the heart to right side abnormally (left-to-right shunt). The congenital heart defects causing this condition include Patent ductus arteriosus (PDA), atrial septal defect (ASD), Ventricular septal defect (VSD), and Atrioventricular canal defect (AV canal). The reversal of this shunt i.e. movement of blood from right side of the heart back to left side (right-to-left shunt) causes insufficient oxygen supply in the blood. This reversal occurs due to increase in blood pressure on the right side of the heart, which causes the blood to flow back to the left side, resulting in mixing of oxygenated and deoxygenated blood, in turn less oxygen supply in the blood. Moreover, continuous high pressure in the lungs causes’ irreversible damage to the blood vessels, fibrosis leading to thrombus formation.
Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Eisenmenger Syndrome Treatment Market : Taxonomy Continuous requirement of medication supports the growth of the Eisenmenger Syndrome Treatment Market. Eisenmenger Syndrome is a chronic disease and requires medication to be taken for a long period of time. The incidence and prevalence of Eisenmenger syndrome has not been properly defined due to the highly specific nature of the condition. However, according to National Center for Biotechnology Information (NCBI), 2010, an estimated 8% of patients with congenital heart disease are expected to develop Eisenmenger syndrome. According to Centers for Disease Control and Prevention (CDC), Congenital Heart Diseases affects nearly 1% or about 40,000 of the births per year in the U.S., 2018. Though technological and healthcare advancements have made it possible to correct congenital heart defects, the responses have been poor in case of patients suffering from Eisenmenger syndrome. Get The Holistic SAMPLE:
https://www.coherentmarketinsights.com/insight/request-sample/1599 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Eisenmenger Syndrome Treatment Market : Key Players ● ● ● ● ● ● ● ● ● ●
Actelion Pharmaceuticals Ltd. Gilead Sciences, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. AstraZeneca plc. Novartis AG Merck & Co. Inc. GlaxoSmithKline plc. Mylan N.V. Bayer AG.
Get TOC Of This Report@ https://www.coherentmarketinsights.com/ongoing-insight/toc/1599
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES Š Coherent market Insights. All Rights Reserved
CUSTOMIZED RESEARCH CONSULT STUDIES
SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
MEDICAL DEVICES
MEDICAL IMAGING
OUR CLIENTS
Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
HEALTHCARE IT
PHARMACEUTICAL
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY STUDIES
GLOBAL REPORTS
100+ Insights Published Per Year
150+ Consulting Projects Till Date
125+
COUNTRY ANALYSIS
CONSULT PROJECTS
SURVEY RESEAR CH
EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT
Clients Worldwide Per Year
110+
TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 Š Coherent market Insights. All Rights Reserved